Explorer
Coronavirus third wave 'dangerous' for kids, vaccine trial approved
Bharat Biotech International Ltd (BBIL) had proposed to carry out a Phase II-III clinical trial of Covaxin in the age group of two to 18 years.
As rapid regulatory response, the proposal was deliberated in Subject Expert Committee (SEC) (Covid-19) on May 11 this year. Coronavirus' third wave can be 'dangerous' for kids, so the necessary steps are being taken care of
India
Sports: Mohammed Aman Reveals the Untold Story Behind Vaibhav Suryavanshi's Rise
Weather alert: Kedarnath Yatra Suspended as Severe Weather Hits Uttarakhand
Breaking: TMC MP Kalyan Banerjee Allegedly Attacked in Hooghly Amid Political Tension in West Bengal
Breaking: Main Accused in Ghaziabad's Surya Murder Case Killed in Police Encounter
Breaking News: Parking Dispute Turns Violent in Himachal’s Kasol
View More
Top Headlines
Cities
Bengal Cabinet Expansion: 35 Ministers to Take Oath Tomorrow, Announces CM Adhikari
India
DK Shivakumar's Karnataka Cabinet: Will Yathindra Siddaramaiah Get A Ministerial Seat?
Cities
'Teach Surya A Lesson': Police Reveal Chilling Detail in Ghaziabad Encounter Case
India
'Question BJP And You Become A Target': Abhishek Banerjee's First Post After Attack
